PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CRSP vs. TWST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CRSP and TWST is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

CRSP vs. TWST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CRISPR Therapeutics AG (CRSP) and Twist Bioscience Corporation (TWST). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-28.19%
-9.44%
CRSP
TWST

Key characteristics

Sharpe Ratio

CRSP:

-0.77

TWST:

0.45

Sortino Ratio

CRSP:

-1.06

TWST:

1.18

Omega Ratio

CRSP:

0.89

TWST:

1.14

Calmar Ratio

CRSP:

-0.49

TWST:

0.37

Martin Ratio

CRSP:

-1.10

TWST:

1.70

Ulcer Index

CRSP:

36.01%

TWST:

18.63%

Daily Std Dev

CRSP:

51.10%

TWST:

69.57%

Max Drawdown

CRSP:

-81.61%

TWST:

-94.48%

Current Drawdown

CRSP:

-80.77%

TWST:

-77.80%

Fundamentals

Market Cap

CRSP:

$3.78B

TWST:

$2.87B

EPS

CRSP:

-$2.79

TWST:

-$3.60

Total Revenue (TTM)

CRSP:

$201.62M

TWST:

$312.97M

Gross Profit (TTM)

CRSP:

$61.70M

TWST:

$133.35M

EBITDA (TTM)

CRSP:

-$313.08M

TWST:

-$176.71M

Returns By Period

In the year-to-date period, CRSP achieves a -35.49% return, which is significantly lower than TWST's 25.23% return.


CRSP

YTD

-35.49%

1M

-14.02%

6M

-32.24%

1Y

-33.59%

5Y*

-9.93%

10Y*

N/A

TWST

YTD

25.23%

1M

11.71%

6M

-5.29%

1Y

31.62%

5Y*

14.24%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CRSP vs. TWST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CRISPR Therapeutics AG (CRSP) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CRSP, currently valued at -0.67, compared to the broader market-4.00-2.000.002.00-0.670.45
The chart of Sortino ratio for CRSP, currently valued at -0.83, compared to the broader market-4.00-2.000.002.004.00-0.831.18
The chart of Omega ratio for CRSP, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.14
The chart of Calmar ratio for CRSP, currently valued at -0.42, compared to the broader market0.002.004.006.00-0.420.37
The chart of Martin ratio for CRSP, currently valued at -0.93, compared to the broader market0.0010.0020.00-0.931.70
CRSP
TWST

The current CRSP Sharpe Ratio is -0.77, which is lower than the TWST Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of CRSP and TWST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
-0.67
0.45
CRSP
TWST

Dividends

CRSP vs. TWST - Dividend Comparison

Neither CRSP nor TWST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CRSP vs. TWST - Drawdown Comparison

The maximum CRSP drawdown since its inception was -81.61%, smaller than the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for CRSP and TWST. For additional features, visit the drawdowns tool.


-82.00%-80.00%-78.00%-76.00%-74.00%-72.00%-70.00%JulyAugustSeptemberOctoberNovemberDecember
-80.77%
-77.80%
CRSP
TWST

Volatility

CRSP vs. TWST - Volatility Comparison

CRISPR Therapeutics AG (CRSP) has a higher volatility of 18.96% compared to Twist Bioscience Corporation (TWST) at 17.73%. This indicates that CRSP's price experiences larger fluctuations and is considered to be riskier than TWST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember
18.96%
17.73%
CRSP
TWST

Financials

CRSP vs. TWST - Financials Comparison

This section allows you to compare key financial metrics between CRISPR Therapeutics AG and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab